ICD in a young patient with syncope

Similar documents
Pearls of the ESC/ERS Guidelines 2015 Channelopathies

How to manage a patient with short QT syndrome?

Clinical and Electrocardiographic Characteristics of Patients with Brugada Syndrome: Report of Five Cases of Documented Ventricular Fibrillation

Syncope in patients with inherited arrhythmogenic syndromes. Is it enough to justify ICD implantation?

ECG Cases and Questions. Ashish Sadhu, MD, FHRS, FACC Electrophysiology/Cardiology

The pill-in-the-pocket strategy for paroxysmal atrial fibrillation

The Role of Defibrillator Therapy in Genetic Arrhythmia Syndromes

Atrial fibrillation in Cardiac Channelopathies

Exercise guidelines in athletes with isolated repolarisation abnormalities and structurally normal heart.

Other 12-Lead ECG Findings

Are there low risk patients in Brugada syndrome?

Διαχείρηση Ασυμπτωματικού ασθενούς με ΗΚΓ τύπου Brugada

ICD THERAPIES: are they harmful or just high risk markers?

The Brugada Syndrome: An Easily Identified and Preventable Cause of Sudden Cardiac Death

Brugada Syndrome: Age is just a number

ΤΙ ΠΡΕΠΕΙ ΝΑ ΓΝΩΡΙΖΕΙ ΟΓΕΝΙΚΟΣ ΚΑΡΔΙΟΛΟΓΟΣ ΓΙΑ ΤΙΣ ΔΙΑΥΛΟΠΑΘΕΙΕΣ

Atrial Fibrillation and Brugada Syndrome

Case Demonstrations in Congenital and Acquired Long QT Syndrome

EHRA Accreditation Exam - Sample MCQs Cardiac Pacing and ICDs

Tailored therapy in long QT syndrome

Syncope: Evaluation of the Weak and Dizzy

CONGENITAL LONG QT SYNDROME(CLQTS) ASSOCIATED WITH COMPLETE ATRIOVENTRICULAR BLOCK. A CASE REPORT.

The impact of clinical and genetic findings on the management of young Brugada Syndrome patients

NATIONAL INSTITUTE FOR HEALTH AND CLINICAL EXCELLENCE

Hereditary Cardiovascular Conditions. genetic testing for undiagnosed diseases

Optimal management of Brugada syndrome

MICS OF MYOCARDIAL ISCHEMIA AND INFARCTION REVISED FOR LAS VEGAS

The Therapeutic Role of the Implantable Cardioverter Defibrillator in Arrhythmogenic Right Ventricular Dysplasia

Παναγιώτης Ιωαννίδης. Διευθυντής Τμήματος Αρρυθμιών & Επεμβατικής Ηλεκτροφυσιολογίας Βιοκλινικής Αθηνών

3/17/2014. NCDR-14 ICD Registry WS # 24 Case Scenarios Including Syndromes w/ Risk of Sudden Death. Objectives

Syncope: Evaluation of the Weak and Dizzy

Clinical Policy: Holter Monitors Reference Number: CP.MP.113

Ripolarizzazione precoce.

IHCP bulletin INDIANA HEALTH COVERAGE PROGRAMS BT JANUARY 24, 2012

Tachycardia Devices Indications and Basic Trouble Shooting

Index. cardiacep.theclinics.com. Note: Page numbers of article titles are in boldface type.

Case Presentation. Asaad Khan University College Hospital Galway Rep of Ireland

WINDLAND SMITH RICE SUDDEN DEATH GENOMICS LABORATORY

Ripolarizzazione precoce. Non così innocente come si pensava

Ripolarizzazione precoce. Torino, 24th October Non così innocente come si pensava

Drugs Controlling Myocyte Excitability and Conduction at the AV node Singh and Vaughan-Williams Classification

Recurrent Implantable Defibrillator Discharges (ICD) Discharges ICD Storm

Name of Presenter: Marwan Refaat, MD

13/09/2018. The ISSUE Studies. International (Italy & Spain) Study of Syncope of Uncertain Etiology. ISSUE study Pre-defined inclusion cathegories

A case of convulsion: Brugada syndrome

Case studies in Channelopathies

Electrophysiologic investigation in Brugada syndrome

ECG ABNORMALITIES D R. T AM A R A AL Q U D AH

J Wave Syndrome: Clinical Diagnosis, Risk Stratification And Treatment Kamal K Sethi,Kabir Sethi,Surendra K Chutani

J Wave Syndromes. Osama Diab Lecturer of Cardiology Ain Shams University

A case of Brugada syndrome coexisting with vasospastic angina: Caution should be taken when using calcium channel blockers

Basics of Structure/Function of Sodium and Potassium Channels Barry London, MD PhD

TACHYARRHYTHMIAs. Pawel Balsam, MD, PhD

IN THE NAME OF GOD. Dr.Sima Sayah

Atrial Fibrillation 10/2/2018. Depolarization & ECG. Atrial Fibrillation. Hemodynamic Consequences

20 ng/ml 200 ng/ml 1000 ng/ml chronic kidney disease CKD Brugada 5 Brugada Brugada 1

ARRHYTHMIAS IN THE ICU

CME Article Brugada pattern masking anterior myocardial infarction

Wojciech Szczepański, MD, PhD Department of Pediatrics, Endocrinology, Diabetology with Cardiology Division Medical University of Bialystok

Heart Rhythm Disorders. How do you quantify risk?

Emergency Medical Training Services Emergency Medical Technician Paramedic Program Outlines Outline Topic: WPW Revised: 11/2013

La strategia diagnostica: il monitoraggio ecg prolungato. Michele Brignole

Index. cardiology.theclinics.com. Note: Page numbers of article titles are in boldface type.

Spontaneous type 1 pattern, ventricular arrhythmias and sudden cardiac death in Brugada Syndrome: an updated systematic review and meta-analysis

Please check your answers with correct statements in answer pages after the ECG cases.

Rhythm Control: Is There a Role for the PCP? Blake Norris, MD, FACC BHHI Primary Care Symposium February 28, 2014

Family Medicine for English language students of Medical University of Lodz ECG. Jakub Dorożyński

Prevention of Sudden Death in ARVC

ARRHYTHMIAS IN THE ICU: DIAGNOSIS AND PRINCIPLES OF MANAGEMENT

Antiarrhythmic Drugs

Rhythm Abnormalities in Children with Isolated Ventricular Noncompaction

Arrhythmias (II) Ventricular Arrhythmias. Disclosures

Short QT syndrome: A case report and review of literature

Subcutaneous Implantable Cardioverter Defibrillator (S-ICD)

ECG Workshop. Carolyn Shepherd And Anya Horne UWE Principles of Cardiac Care

PEDIATRIC EKG WORKSHOP

FANS Paediatric Pathway for Inherited Arrhythmias*

Sudden Cardiac Death What an electrophysiologist thinks a cardiologist should know

Synopsis of Management on Ventricular arrhythmias. M. Soni MD Interventional Cardiologist

Asymptomatic patient with WPW

Silvia G Priori MD PhD

Basic electrocardiography reading. R3 lee wei-chieh

ECG S: A CASE-BASED APPROACH December 6,

Tachycardias II. Štěpán Havránek

Sustained tachycardia with wide QRS

Sudden Cardiac Death and Asians Disclosures

Step by step approach to EKG rhythm interpretation:

SEMINAIRES IRIS. Sudden cardiac death in the adult. Gian Battista Chierchia. Heart Rhythm Management Center, UZ Brussel. 20% 25% Cancers !

ECGs and Arrhythmias: Family Medicine Board Review 2009

The Early Repolarization ECG Pattern An Update

Targeting the late sodium channel: A new antiarrhythmic paradigm?

Noninvasive Predictors of Sudden Cardiac Death

ECG Interpretation Cat Williams, DVM DACVIM (Cardiology)

Chapter 9. Learning Objectives. Learning Objectives 9/11/2012. Cardiac Arrhythmias. Define electrical therapy

Treatment of Arrhythmias in the Emergency Setting

Interpretation and Consequences of Repolarisation Changes in Athletes

REtrive. REpeat. RElearn Design by. Test-Enhanced Learning based ECG practice E-book

The Short QT Syndrome

Quinidine for Brugada syndrome: Panacea or poison?

FAMILIAR, CONGENITAL OR HEREDITARY SHORT QT SYNDROME: GUSSAK SYNDROME. UPDATE

Transcription:

ICD in a young patient with syncope Konstantinos P. Letsas, MD, FESC Second Department of Cardiology Evangelismos General Hospital of Athens Athens, Greece

Case presentation A 17-year-old apparently healthy young man with recurrent syncopal episodes during walking was referred to our institution for further evaluation. There was no family history of sudden cardiac death. Transthoracic echocardiography revealed a structurally normal heart. Exercise treadmill test failed to induce any arrhythmic or ischemic events. A drug-free tilt table test was negative for neurocardiogenic syncope.

Baseline ECG

Baseline ECG Brugada pattern? Early repolarization? Short QT interval?

Holter monitoring

Abrupt AV block Autonomic nervous system dysfunction (enhanced vagal tone)? AV nodal blocking agents? Distal conduction disease? Concealed His bundle extrasystoles?

SAECG and Brugada test Late potentials (RMS-40, LAS-40) as detected and calculated by signalaveraged ECG were positive. Sodium channel blocking test with procainamide (10 mg/kg) failed to induce the diagnostic type 1 ECG of Brugada syndrome.

Electrophysiological study EPS demonstrated normal AH (110 ms) and HV (49 ms) intervals. Right ventricular programmed stimulation at three basic cycle lengths (600, 500 and 430 m) with up to three extra stimuli failed to induce any ventricular arrhythmias. The atrial and ventricular refractory periods were 190 and 200 ms, respectively No atrial arrhythmias were induced and no episodes of AV block were documented during EPS.

ICD implantation A dual-chamber cardioverter defibrillator (ICD) was implanted. The patient was asymptomatic after a 12-month follow-up period. Careful programming of the defibrillator function and adaptation of sensing levels and decay delays are essential in SQTS to reduce inappropriate shocks related to atrial tachyarrhythmias or T-wave oversensing.

Genetic test Genomic DNA was prepared from peripheral blood lymphocytes using standard methods. The entire open reading frame of the KCNQ1, KCNH2 and SCN5A genes was analyzed. The following non-coding genetic variants were identified: KCNQ1 (1638 G[A S546S), KCNH2 (G3152? 22 G[A) and SCN5A (5457 C[T D1819D, 3183 G[A E1061E). The KCNJ2, CACNA1C and CAC-NB2 genes were not screened for mutations.

Short QT syndrome HOW SHORT IS SHORT???? QTc <330 msec (none in 12,012 apparently healthy subjects, Gallagher et al. Am J Cardiol; 2006) A QTc value <350-360 msec needs further validation. Hyperkalemia, hypercalcemia, acidosis, digoxin overdose, fever, tachycardia, vagal or sympathetic hypertonia, and acute ischemia, early repolarization.

J Am Coll Cardiol 2011;57:802 12

Diagnostic Criteria for SQTS: >4 points J Am Coll Cardiol 2011;57:802 12

SQTS: diagnosis ESC guidelines 2015 SQTS is diagnosed in the presence of a QTc 340 ms. SQTS should be considered in the presence of a QTc 360 ms and one or more of the following: A confirmed pathogenic mutation A family history of SQTS A family history of sudden death at <40 years Survival from a VT/VF episode in the absence of heart disease.

Genes implicated in SQTS Cardiol J 2013; 20, 5: 464 471

Other ECG findings in SQTS Absent or minimal ST segments Interval from J point to T wave peak (Jp-Tp) measured in the precordial lead with the T wave of greatest amplitude < 120 ms Possible tall T waves with narrow base similar to the T wave of moderate hyperkalemia ( desert tent T waves ) Frequent early repolarization pattern Prolongation of Tpeak-Tend interval Possible presence of prominent U waves Very frequent paroxysmal AF Cardiol J 2013; 20, 5: 464 471

The minus-plus T-wave signal Cardiol J 2013; 20, 5: 464 471

PQ segment depression in patients with SQTS Heart Rhythm2014;11:1024 1030

SQTS ECG Courtesy of S. Priori

SQTS ECG Courtesy of S. Priori

EPS in SQTS Extremely short atrial refractory period (<140 ms) and ventricular refractory period (<150 ms) Atrial refractory periods of < 140 ms and ventricular effective refractory periods of <150 ms are highly suspicious of SQTS. Increased inducibility of AF and ventricular fibrillation (VF). Cardiol J 2013; 20, 5: 464 471

VF three years later

Thank you very much for your attention